• 2013

Company Description

Visgo Therapeutics develops products to treat joint diseases.

Visgo is developing best in class products to treat joint diseases, such as osteoarthritis. Using a proprietary delivery platform, these products will be locally delivered for release over time within the joint with minimal systemic exposure. Our first product, VG201, delivers an NSAID by sustained release for the treatment of knee osteoarthritis pain, and is now in preclinical testing.